Amylyx Pharmaceuticals (AMLX) Asset Utilization Ratio (2022 - 2025)
Amylyx Pharmaceuticals (AMLX) posted quarterly Asset Utilization Ratio of 0.0 for Q3 2025, down 100.34% year-over-year from 0.68 in Q3 2024, and down 114.88% quarter-over-quarter from 0.0 in Q2 2025.
Amylyx Pharmaceuticals (AMLX) Asset Utilization Ratio (2022 - 2025) Analysis & Trends
Amylyx Pharmaceuticals' Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.0 for Q3 2025.
- In Q3 2025, Asset Utilization Ratio fell 100.34% year-over-year to 0.0; the TTM figure through Sep 2025 stood at 0.0 (down 100.34% YoY), while the FY2024 annual figure was 0.25, down 70.66% from the prior year.
- Asset Utilization Ratio for Q3 2025 stood at 0.0, down from 0.0 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.85 in Q1 2024, with the low at 0.0 in Q3 2025.
- The 4-year median for Asset Utilization Ratio is 0.42 (2023), against an average of 0.41.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio soared 884.63% in 2023, then tumbled 100.34% in 2025.
- Amylyx Pharmaceuticals' Asset Utilization Ratio stood at 0.08 in 2022, then jumped by 884.63% to 0.77 in 2023, then sank by 47.98% to 0.4 in 2024, then slumped by 100.57% to 0.0 in 2025.
- Business Quant data shows AMLX's Asset Utilization Ratio at 0.0 in Q3 2025, 0.0 in Q2 2025, and 0.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Amylyx Pharmaceuticals | 4.34 Bn | 4.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.40 |
| Sep 30, 2024 | 0.68 |
| Jun 30, 2024 | 0.80 |
| Mar 31, 2024 | 0.85 |
| Dec 31, 2023 | 0.77 |
| Sep 30, 2023 | 0.64 |
| Jun 30, 2023 | 0.45 |
| Mar 31, 2023 | 0.23 |
| Dec 31, 2022 | 0.08 |